New Jersey A 1646: Establishes prescription drug pricing disclosure requirements and measures to reduce prescription drug costs.

Status: Introduced in the Assembly, Referred to Assembly Financial Institutions and Insurance Committee (as of 2024-01-09)

State: New Jersey · Session: 221 · Bill: A 1646

Subjects: PHARMACEUTIC

Sponsors: Bailey, David, Simmons, Heather

View New Jersey A 1646 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.